Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-055990

Chief Executive Officer sold 7,800 shares at an average $33.95 ($264,796)

From the SEC's structured data for this filing

Trades in this filing

Ciechanover Isaac E. · Chief Executive Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2018-10-22 Sale : show line 1 in the form −3,105 $33.66 $104,514 47,773 I
2018-10-22 Sale : show line 2 in the form −795 $34.26 $27,237 46,978 I
2018-10-23 Sale : show line 3 in the form −1,400 $33.17 $46,438 45,578 I
2018-10-23 Sale : show line 4 in the form −1,700 $34.39 $58,463 43,878 I
2018-10-23 Sale : show line 5 in the form −800 $35.18 $28,144 43,078 I
Open-market sales · 7,800 sh · avg $33.95 · $264,796
Loading xslF345X03/doc4.xml…